Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
After finishing at $6.16 in the prior trading day, LifeStance Health Group Inc (NASDAQ: LFST) closed at $6.13, down -0.49%. In other words, the price has decreased by -$0.49 from its previous closing price. On the day, 1.31 million shares were traded. LFST stock price reached its highest trading level at $6.215 during the session, while it also had its lowest trading level at $6.03.
Ratios:
Our goal is to gain a better understanding of LFST by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 15.25 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 27.51. For the most recent quarter (mrq), Quick Ratio is recorded 1.37 and its Current Ratio is at 1.37. In the meantime, Its Debt-to-Equity ratio is 0.34 whereas as Long-Term Debt/Eq ratio is at 0.30.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, KeyBanc Capital Markets on April 08, 2025, initiated with a Overweight rating and assigned the stock a target price of $9.
On April 03, 2025, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $8.
Goldman Upgraded its Neutral to Buy on December 16, 2024, while the target price for the stock was maintained at $10.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 09 ’25 when Bessler Robert sold 4,900 shares for $7.01 per share. The transaction valued at 34,349 led to the insider holds 1,421,990 shares of the business.
Bessler Robert sold 14 shares of LFST for $98 on Apr 08 ’25. The Director now owns 1,424,440 shares after completing the transaction at $7.00 per share. On Apr 09 ’25, another insider, Bessler Robert, who serves as the Director of the company, bought 4,900 shares for $7.01 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LFST now has a Market Capitalization of 2576488192 and an Enterprise Value of 2687909376. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.88 while its Price-to-Book (P/B) ratio in mrq is 1.62. Its current Enterprise Value per Revenue stands at 2.149 whereas that against EBITDA is 63.872.
Stock Price History:
The Beta on a monthly basis for LFST is 1.26, which has changed by -0.006482959 over the last 52 weeks, in comparison to a change of 0.042615533 over the same period for the S&P500. Over the past 52 weeks, LFST has reached a high of $8.61, while it has fallen to a 52-week low of $4.64. The 50-Day Moving Average of the stock is -14.35%, while the 200-Day Moving Average is calculated to be -11.45%.
Shares Statistics:
The stock has traded on average 1.74M shares per day over the past 3-months and 1793750 shares per day over the last 10 days, according to various share statistics. A total of 382.74M shares are outstanding, with a floating share count of 115.87M. Insiders hold about 69.87% of the company’s shares, while institutions hold 35.02% stake in the company. Shares short for LFST as of 1743379200 were 8565591 with a Short Ratio of 4.91, compared to 1740700800 on 8398230. Therefore, it implies a Short% of Shares Outstanding of 8565591 and a Short% of Float of 10.459999999999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The market rating for LifeStance Health Group Inc (LFST) is a result of the insights provided by 1.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is $0.01, with high estimates of $0.01 and low estimates of $0.01.
Analysts are recommending an EPS of between $0.06 and $0.06 for the fiscal current year, implying an average EPS of $0.06. EPS for the following year is $0.09, with 1.0 analysts recommending between $0.09 and $0.09.
Revenue Estimates
5 analysts predict $332.69M in revenue for the current quarter. It ranges from a high estimate of $333.98M to a low estimate of $330.15M. As of the current estimate, LifeStance Health Group Inc’s year-ago sales were $300.44MFor the next quarter, 5 analysts are estimating revenue of $352.48M. There is a high estimate of $356.1M for the next quarter, whereas the lowest estimate is $350.16M.
A total of 8 analysts have provided revenue estimates for LFST’s current fiscal year. The highest revenue estimate was $1.42B, while the lowest revenue estimate was $1.41B, resulting in an average revenue estimate of $1.42B. In the same quarter a year ago, actual revenue was $1.25BBased on 7 analysts’ estimates, the company’s revenue will be $1.61B in the next fiscal year. The high estimate is $1.64B and the low estimate is $1.57B.
